Calcium has been implicated as a regulatory factor in many physiological and pathophysiological processes in the renal cell. Under physiological conditions, the cytosolic free calcium concentration is maintained at approximately 100 nM. Most of the releasable cell Ca2' resides in the nonmitochondrial compartments. In addition to the plasma membrane Ca2+ transport processes, there is a high-affinity, low-capacity buffering capability of nonmitochondrial organelles and a lower-affinity high-capacity mitochondrial Ca2+ buffering capability.
permeabilized renal mesangial cells, the [Ca2+1 dependency of phospholipase A2 was characterized. The [Ca2+] sensitivity was insufficient to explain the phospholipase A2 activation observed with vasopressin. In both intact cells, as well as permeabilized cells, it was found that protein kinase C activation markedly enhanced the Ca2' calmodulin-dependent activation of phospholipase A2.
In response to platelet-derived growth factor, it was found that arachidonic acid release preceded phospholipase C activation. This suggests that other effectors besides Ca2+ and protein kinase C may also be important for phospholipase A2 activation.
In an experimental model designed to mimic postischemic reperfusion damage to renal mitochondria, it was demonstrated that reactive oxygen species act synergistically with Ca21 to activate mitochondriAl phospholipase A2, which mediates damage to site I of the electron transport chain, the FyFQ ATPase, and the adenine nucleotide translocase. of Mg2" and ATP, small amounts of Ca2" added to digitonin-permeabilized cells are taken up via a vanadate-inhibitable, ruthenium red-insensitive process into a nonmitochondrial compartment (3). This compartment buffers Ca2" such that [Ca2"]f is maintained in the 50 to 300 nM range. Thus, under physiological conditions, most of the cell Ca2" stored in membranebound releasable form is located in a nonmitochondrial compartment that may be the endoplasmic reticulum, a subcompartment of the endoplasmic reticulum, or other organelles (4). The Ca2" transport characteristics of this compartment are likely to be important for the maintenance of cytosolic Ca2" concentrations close to basal levels, in spite of minor fluctuations in plasma membrane transport or permeability characteristics. With the continued addition of Ca2" to permeabilized cells, this compartment is saturated with Ca2', and the additional Ca2" is buffered by the mitochondria, a high-capacity Ca2" buffering compartment. While mitochondria can take up very large amounts of Ca2", the resultant free extramitochondrial Ca2" concentration is in the 600 to presented to the cell, as when the cell is exposed to a toxic or ischemic influence, the nonmitochondrial stores are rapidly saturated, and the mitochondria assume the primary role of Ca2" buffer (3).
Physiological and Pathophysiological Roles of Phospholipase A2
One of the effector enzymes that serves as a critical transducer of Ca2" action in the cell is phospholipase A2. This enzyme cleaves the fatty acid from the sn-2 position of phospholipids. Since many cellular phospholipids are enriched in arachidonic acid in the sn-2 position, phospholipase A2 activation results in enhanced levels of free arachidonic acid, which is the precursor for an entire family of metabolically active substances: prostaglandins, leukotrienes, Hete's, epoxides, and thomboxanes.
It is believed by most, but not all, investigators that the production of free arachidonic acid is rate limiting for synthesis of these compounds, thus placing phospholipase A2 at the critical regulatory step. With the exception of phospholipase A2 of lysosomal origin, most of the phospholipase A2 enzymes characterized to this point require Ca' for activation (5) .
Free arachidonic acid and its products may serve as intracellular messengers (6) and may activate other phospholipases involved in the signal cascade modulating the cellular responses to activating stimuli. In addition to these effects on signal transduction, many of the results of phospholipase A2 activation may be manifested on other cells in the tissue of origin or other tissues in the organism since many of the arachidonic acid cascade products are secreted (7, 8) .
In addition to the physiological regulatory effects of phospholipase A2 activation products, there are many potential adverse consequences to the cell and organism (9) . For example, prostaglandins, leukotrienes, and thromboxanes are mediators of inflammation (10) . Also, the free fatty acids (11) (12) (13) (14) (15) and lysophospholipids (16) that result from phospholipase A2-induced phospholipid hydrolysis are very toxic to the cell. The mitochondria are important targets of phospholipase A2 action, resulting in adverse consequences to the cell. Activation of mitochondrial phospholipase A2 results in hydrolysis of cardiolipin (diphosphatidylglycerol), a lipid that is a critical component of the catalytic subunits of the electron transport chain (complexes I, III, and cytochrome oxidase) (17) , ATP synthase (18, 19) , and adenine nucleotide translocase (20) . Cone-shaped lipids, such as cardiolipin, may increase the susceptibility of other membrane phospholipids to phospholipase A2 action by decreasing the packing of polar head groups (21) .
Therefore, because of the implications for understanding the physiological response of cells to activating stimuli and the need to understand the events triggering cell and tissue injury, it is important to understand the regulation of phospholipase A2 and the role played by Ca2" in its activation.
Ca2+-Dependent Activation of Phospholipase A2
A standard model for cell activation by an agonist, such as vasopressin resulting in phospholipase A2 activation, can be described as follows: Hormonereceptor interaction results in the activation of phospholipase C. This process is mediated by a guanine nucleotide-binding protein in many cells, including the mesangial cell (22 (2) . This increase in [Ca2+]f is due primarily to its release from intracellular storage sites, since the reduction of extracellular [Ca2+] with EGTA only modulates the response minimally. There is an associated 10-fold increase in prostaglandin E2 production by these cells that is not affected by changing extracellular [Ca2+] over three ranges (< 100 nM, 1-10 gM, 1.5 mM) (22) . This insensitivity of prostaglandin synthesis to extracellular [Ca2'] is consistent with the view that release of Ca21 from intracellular stores, rather than entry of Ca2+ across the plasma membrane, may be responsible for the prostaglandin E2 production.
The level of the Ca2+ concentration necessary to stimulate phospholipase A2 in many assay systems, however, is significantly higher than that achieved with hormone activation (22, 23) . Likewise, under conditions of ischemic and toxic injury, [Ca2+]f increases to levels lower than those predicted to be necessary to activate the enzyme in vitro, although damage has occurred to the cell that has been proposed to be phospholipase A2 related (24, 25) .
It is possible that these apparent inconsistencies between the Ca21 concentrations necessary to activate the enzyme in cell-free systems and the levels achieved in the intact cell may be due to the absence of important cofactors or the enhanced expression of endogenous inhibitor activity in the assay system in vitro (26) . Alternatively, other modulatory factors that are present in the intact cell upon activation but absent in the cell-free system may account for the differences. In order to address this issue, we examined the Ca2+ dependency of phospholipase A2 activity under experimental conditions designed to maintain the enzyme in its normal configuration in the cell. PGE2 synthesis was measured as a function of cytosolic [Ca2"] in cells rendered permeable with digitonin.
[Ca2+] was clamped secondary to the large amount of incubation media relative to cell mass and the free communication between the cytosolic compartment and bath.
[Ca2"] was measured with a Ca2' electrode (2). When [Ca2+] varied over the range from < 100 nM to 100 gM, there was a progressive increase in PGE2 production (Fig. 1) . The increase was modest, but nevertheless apparent over the physiological range (100 nM-2 gM).
Calmodulin inhibitors (22, 27) decreased PGE2 synthesis at all concentrations of [Ca2+]. The addition of exogenous calmodulin had no effect on PGE2 production at any level of [Ca2"], presumably because the cell permeabilization procedure did not result in loss of calmodulin in sufficient quantities to compromise phospholipase A2 function (22) .
To establish that the increase in PGE2 production was associated with an increase in acylhydrolase activity, arachidonic acid release was measured in cells prelabeled with 3H-arachidonic acid. Release was determined as a function of Ca2+ with [Ca2+] fixed at three different levels (< 100 nM, 1-10 gM, and 500 gM) in digitonin-permeabilized cells. As depicted in Table 1 , free arachidonic acid increased as a function of Ca2' concentration in a manner that paralleled the PGE2 production. In addition, 3H-diglyceride levels were increased with increasing [Ca2+]. This latter finding of increases in diacylglycerol with increasing (50 gM), a calmodulin inhibitor (28) , inhibited the arachidonic acid release. Furthermore, the phospholipase A2 inhibitors, dibucaine and mepacrine, inhibited the Ca2+-dependent arachidonic acid release, but they had no effect on the Ca2+-dependent increases in 3H-diglyceride (22) . reached with vasopressin, PMA resulted in an approximate 100% increase in PGE2 production over that seen with Ca2' alone (22) . This increase induced by PMA resulted in a net PGE2 production in the permeabilized cell that roughly equaled that in the vasopressin-stimulated intact cell (Fig. 2 ).
To further demonstrate that the increase in calcium concentration was necessary, albeit not sufficient to explain the enhanced levels of phospholipase A2 activity, we exposed permeabilized cells to vasopressin (100 nM) in the presence of 100 FM GTPyS in order to stimulate phospholipase C. Under these conditions there was a significant increase in 3H-diglyceride (1.55 ± 0.14% of total radioactivity to 2.37 + 0.29%, n = 8, p < 0.01). There was, however, no increase in free arachidonic acid (22) . Thus, under conditions where phospholipase C and presumably protein kinase C were activated, there was no stimulation of phospholipase A2 if [Ca2']f was maintained at low basal cellular levels.
To establish that this synergistic effect between Ca2' and PMA that was seen in permeabilized cells was also present in intact cells, we examined free arachidonic acid levels in intact cells stimulated with A23187, PMA, A23187 + PMA, or vasopressin alone for 10 min (Fig. 3) . At low doses of the calcium ionophore, A23187, 0.1 gM, only a slight increase occurred in arachidonic acid release. PMA alone had no effect on arachidonic acid release. In spite of this small effect of ionophore and no effect of PMA alone, both added together resulted in a marked stimulation of arachidonic acid release, reflecting a synergistic interaction. (22) .
and lower concentrations of PMA (10 nM), and also longer time periods for stimulation (30 min), the levels of free arachidonic acid far exceeded that of vasopressin alone (22) . To demonstrate further that this effect of PMA was due to an effect of protein kinase C and not a nonspecific effect of phorbol esters, we used the diacylglycerol analogue, 1-oleoyl 2-acetylglycerol. This analogue also worked synergistically with A23187 to increase free arachidonic levels in intact mesangial cells (22) .
We concluded from this data that agonist-induced (35) found that pertussis toxin modulated agonistinduced PGE2 synthesis. Our data, indicating no activation of phospholipase A2 with GTP-yS under conditions of very low cytosolic calcium concentrations, do not rule out a potential role for a GTP-binding protein in phospholipase A2 activation when cytosolic calcium levels are increased. Protein kinase C may also activate a Na+/H+ exchange process (36), which we have identified to be present in the mesangial cell (37) . This in turn may activate phospholipase A2 by a phospholipase C-independent mechanism, as has been reported in the platelet (38) . This would not however explain the PMA effect in the permeabilized cell where the pH was clamped.
Phospholipase C-Independent Activation of Phospholipase A2
Many agonists that increase phospholipase A2 activity in cells increase phospholipase C activity promptly upon interaction with their receptors, resulting in an inability to distinguish a phospholipase C-dependent activation of phospholipase A2 mediated by IP3 and an increase in
[Ca2+]f and protein kinase C activity from a potential phospholipase C-independent mechanism of phospholipase A2 activation. We were able to dissociate the two effects for the first time in a nucleated intact cell preparation by examining phospholipase C and phospholipase A2 activation patterns in response to platelet-derived growth factor (PDGF) (39) . PDGF increases [Ca2+]f in mesangial cells. However, in contrast to vasopressin and platelet-activating factor that increased Ca2+ to peak levels in less than 10 sec of agonist stimulation, PDGF increases [Ca2+]f levels much more slowly, with the peak response occurring at 1 min. This slow [Ca2']f activation pattern is seen at a number of different concentrations of PDGF, ranging from 0.005 units/mL to 5 units/mL. One possible explanation for this delay in the peak Ca2' response is that PDGF-induced stimulation of phospholipase C may also be delayed. As indicated in Figure 4 , when either inositol phosphate or diacylglycerol levels were determined at 15 sec after PDGF stimulation, there was no significant increase in phospholipase C activation. On the other hand, by 2 min there was an approximately 100% increase in the diacylglycerol and inositol phosphate levels. By contrast, free arachidonic levels increased by more than 100% within the first 15 sec of PDGF stimulation. This indicates, therefore, that in response to PDGF there is a rapid increase in phospholipase A2 that precedes the peak in Ca2`response. This suggests a Ca2+-independent phospholipase C-independent mechanism for activation of phospholipase A2. This phospholipase Cindependent pathway for phospholipase A2 activation may involve GTP-binding proteins or may involve other events within the cell. For example, it is possible that the Na+/H+ exchange activation that is seen by some investigators with PDGF in other cell types (41) may activate phospholipase A2 in the mesangial cell in a manner that is similar to that postulated in the platelet (42) . Another possible explanation for the activation of phospholipase A2 might be a change in membrane potential which has been shown to activate the enzyme when incorporated into lipid bilayers (43 Potential damaging effects of these agents on mitochondrial function may result in impaired ATPase synthesis and abnormal cellular bioenergetic processes, leading ultimately to cell death. In order to model in vitro conditions mimicking the mitochondrial environment in vivo resulting from exposure of the cell to toxic and ischemic influences, mitochondria were exposed to Ca2' and reactive oxygen species generated by hypoxanthine and xanthine oxidase in the presence of iron. Ca2+ treatment of mitochondria alone had no detrimental effects on mitochondria bioenergetics. By contrast, Ca21 pretreatment followed by the exposure to reactive oxygen species resulted in complete uncoupling of oxidative phosphorylation. There was an associated defect in the electron transport chain when site I substrates were used (Fig. 5) We have postulated one possible model for this synergistic interaction between Ca2" and phospholipase A2 (44) . Reactive oxygen species may initially increase the permeability of the mitochondria outer and inner membranes. Phospholipase A2, located predominantly in the outer membrane, may be activated by mitochondrial Ca21 influx. Lipid peroxidation by reactive oxygen species may enhance the susceptibility of these membranes to the action of activated phospholipase A2 (45) . Phospholipase A2 may permeate the inner membrane gaining access to and causing degradation of the electron transport chain, ATPase, and translocase. The mitochondrial membrane has a high content of diphosphatidylglycerol (cardiolipin), a critical component of the catalytic subunits of the electron transport chain (17) , ATP synthase (18, 19) and adenine nucleotide translocase (20) . With its high concentration of unsaturated fatty acids (46) and its cone-shaped configuration (21) , it may confer particularly high susceptibility of these mitochondrial sites to the action of phospholipase A2.
Summary
Fundamental to an understanding of the role of 
